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Abstract 
Background: Temperament and character profiles have been associated with depression outcome and 
alcohol abuse comorbidity in depressed patients. How harmful alcohol use modifies the effects of 
temperament and character on depression outcome is not well known. Knowledge of these associations 
could provide a method for enhancing more individualized treatment strategies for these patients. 
Methods: We screened 242 depressed patients with at least moderate level of depressive symptoms. The 
Alcohol Use Disorders Identification Test (AUDIT) was used for identifying patients with marked alcohol use 
ƉƌŽďůĞŵƐ;hW͕h/dшϭϭͿ͘ĨƚĞƌϲǁĞĞŬƐŽĨĂŶƚŝĚĞƉƌĞƐƐŝǀĞƚƌĞĂƚŵĞŶƚϭϳϯƉĂƚŝĞŶƚƐǁĞƌĞĂƐƐĞƐƐĞĚƵƐŝŶŐ
the Montgomery-Åsberg Depression Rating Scale (MADRS), and the Temperament and Character Inventory 
(TCI-R). Outcome of depression (MADRS scores across three follow-up points at 6 weeks, 6 months and 24 
months) was predicted with AUP, gender, and AUP x Gender and AUP x Time interactions together with 
temperament and character dimension scores in a linear mixed effects model.  
Results: Poorer outcome of depression (MADRS scores at 6 weeks, 6 months and 24 months) was predicted 
by AUP x Time interaction (p=0.0002) together with low Reward Dependence (p=0.003). Gender and all 
other temperament and character traits were non-significant predictors of the depression outcome in the 
mixed effects model. 
Conclusions: Possibly due to the modifying effect of alcohol use problems, high Reward Dependence was 
associated with better depression treatment outcome at 6 months. Harm Avoidance and Self-Directedness 
did not predict depression outcome when alcohol use problems were controlled. 
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1. Introduction2 
It is well known that comorbidity of major depressive disorder (MDD) with substance use disorders (SUDs) 
can lead to impaired response to treatment, more chronic disease courses or recurrence of depressive 
episodes [1,2]. Because recurrent and chronic depression constitute a major burden of disease [1,2], more 
efficient treatment strategies and means for earlier identification of high-risk patients are needed.  
Assessment of individual temperament and character traits could provide a method for enhancing 
preventive and more individualized treatment strategies for these patients because certain traits and 
temperaments may predispose individuals to recurrence of depression, and are associated with different 
courses of depression and with substance use disorder comorbidity and drinking outcomes [3-6]. Individual 
personality could have pathoplastic effects on recovery from depression; i.e., differences in temperament 
or character could explain differences in the course of the illness [7]. How harmful alcohol use modifies the 
effects of temperament and character on depression outcome is not well known. 
The Temperament and Character inventory (TCI-R) is a 240-item questionnaire that collects information on 
human personality in the context of temperament and character. According to Cloninger’s psychobiological 
model, on which the TCI-R was based, temperament is divided into four dimensions: Novelty Seeking (NS), 
Harm Avoidance (HA), Reward Dependence (RD) and Persistence (P). Character is divided into three 
dimensions: Self-Directedness (SD), Cooperativeness (C) and Self-Transcendence (ST) [8]. These dimensions 
are thought to reflect combinations of different neurocognitive functions (e.g., memory or reward 
functions), and the biological basis of this model is supported by many findings [9,10].  
According to Cloninger’s theory, temperament dimensions generally represent a stable part of personality, 
and only HA has shown clear state-dependent changes during depression [4,5,8]. However, high HA – and 
more particularly its sub-scores, anticipatory worry (HA1) and fatigability (HA4) – have also manifested as 
                                                          
2 Abbreviations: MDD = major depressive disorder, SUD = substance use disorder, NS = Novelty Seeking, HA = Harm 
Avoidance, RD = Reward Dependence, P = Persistence, SD = Self-Directedness, C = Cooperativeness, ST = Self-
Transcendence, AUP = alcohol use problems, MADRS = Montgomery-Åsberg Depression Rating Scale, TCI-R = 
Temperament and Character Inventory 
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trait-like markers for risk of depression, i.e., index episodes, relapses or recurrent episodes and impaired 
treatment response [4,5]. High RD could be protective against depression in general population, but no 
associations have been reported with outcome of depression in clinically depressed patients [4,11-15]. Our 
earlier study of this patient sample suggested that RD is associated with depression treatment outcome in 
patients with alcohol use problems as change in RD was strongly associated with acute treatment response 
(0-6 weeks) to depression when alcohol use was taken into account [16]. High NS is a trait indisputably 
associated with risk of substance use disorders, more severe symptomatology and poorer outcome in SUD 
patients, and apparently experienced at a higher level in patients with dual diagnosis (concurrent SUD and 
mental illness) than in depressed patients [3,6,17-20]. Low P and high HA are associated with more severe 
alcohol dependence symptomatology [21-23].  
Of the character traits, low SD is the trait most clearly predisposing to depression and recurrence of 
episodes, possibly because individuals with deficiencies in sub-traits such as self-acceptance, responsibility, 
goal-directedness associated with SD may be more prone to depression due to difficult situations 
encountered in their daily lives [24,25]. There is less evidence to suggest that low C is associated with the 
development of depression, whereas findings on the associations between ST and depression in different 
patient samples have been contradictory [4,15,26,27]. Low SD is also associated with more severe 
symptomatology and drinking outcomes in SUD patients [6,28,29]. In alcohol dependence character profile 
with high ST and low SD and C is associated with depression and anxiety [21].  
In spite of a large body of knowledge of different associations separately between temperament and 
character traits and depression or substance use disorders, we found no follow-up studies addressing the 
associations between depression outcome and temperament, character and alcohol use. We investigated 
whether temperament and character trait scores (at 6 weeks) together with harmful alcohol use predict 
outcome of depression in follow-up from 6 weeks to 6 months and to 24 months in a clinically diverse 
sample of depressed patients. In light of earlier evidence we hypothesize that high HA and low SD and 
harmful alcohol use together explain poorer depression treatment outcome (measured as MADRS scores) 
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[4,5,25]. As harmful alcohol use had a modifying effect on both temperament and character dimensions 
during acute illness, we hypothesize that RD together with alcohol use is also associated with outcome of 
depression in the long-term follow-up (from 6 weeks to 6 and 24 months) [16]. High NS has been associated 
with more severe SUDs, and therefore we also hypothesized that this temperament trait might modify 
treatment outcome together with harmful alcohol use in depression [6].  
2. Methods 
2.1 Participants 
In the period 2009 - 2013, 242 patients were screened for the study in the Finnish region of Southern 
Ostrobothnia (population 200,000). These patients were referred to psychiatric specialized care units (5 
outpatients and 1 inpatient) due to depression, anxiety, self-destructiveness, insomnia or alcohol-related 
problems. To maximize clinical relevance, lenient inclusion criteria were used. Patients with at least 
moderate depressive symptomatŽůŽŐǇ;ĞĐŬĞƉƌĞƐƐŝŽŶ/ŶǀĞŶƚŽƌǇ΀/΁sĞƌƐŝŽŶϭ͕ƐĐŽƌĞшϭϳ͖[30]) were 
included in the study. Patients with organic brain disease or psychotic disorder (ICD-10 F2* diagnosis) were 
excluded. Their age range was 17–64 years (mean 38.8 years, SD±12.2). A more detailed description of the 
sample is presented in Tables 1a and 1b, and of the study setting elsewhere (see ClinicalTrials.gov Identifier 
NCT02520271, Ostrobothnia Depression Study [ODS], 2016). The study was approved by the local Human 
Subjects Review Committee, and patients gave their informed written consent. 
[Tables 1a and 1b] 
2.2 Procedures 
Sociodemographic data were collected and clinical assessments conducted at screening (the Alcohol Use 
Disorders Identification Test (AUDIT) [31] and the BDI). There was some dropout before the baseline 
assessment using the Mini International Neuropsychiatric Interview 5.0 (MINI; [32]) and the Montgomery-
Åsberg Depression Rating Scale (MADRS) [33] and 228 (94%) patients were assessed with MADRS at 
baseline. According to the MINI administered to 219 patients (data missing in 23 cases), 88.6% of the 
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patients had MDD, 4.1% dysthymic disorder, 5.5% anxiety disorder and 0.4% alcohol use disorder (AUD) as 
their main diagnosis, and 1.4% of the patients did not meet any of the diagnostic criteria. Twelve percent 
(12%) of the patients met the criteria for lifetime diagnosis of (hypo)manic episode. Sixty-three percent 
(63%) of patients with mood disorder as their main diagnosis had comorbid anxiety disorders, 
corresponding well to comorbidity proportions found in other samples in Finnish psychiatric secondary 
services [34]. Six patients (3%) with mood disorder as primary diagnosis had comorbid bulimia nervosa. 
Patients’ categorical personality disorder diagnoses were not assessed. In the total sample, 33.6% of the 
patients reported that this was their first episode of MDD. 
At baseline patients attended an appointment with a psychiatrist, where their medication was evaluated 
and changed if necessary. Antidepressant medication was prescribed to 206 patients (85%) with mean 
fluoxetine equivalent daily doses of 33.0 mg (SD±18.3). Of these, 82% had either an SSRI or SNRI as a 
primary antidepressant. Adherence to antidepressants was monitored during the first six weeks of the 
study using a paper and pencil diary (for more information see [16]). All patients received behavioral 
activation therapy with trained clinical staff. The median number of therapy sessions with patients was 6 
(IQR = 3-11) with sessions taking place at 1 to 2-week intervals. The treatment of patients with alcohol use 
ƉƌŽďůĞŵƐ;hW͕h/dƐĐŽƌĞƐшϭϭͿǁĂƐĞŶŚĂŶĐĞĚǁŝƚŚŵŽƚŝǀĂƚŝŽŶĂůŝŶƚĞƌǀŝĞǁing (median number of 
sessions 4, IQR = 3-6) at the start of the treatment according to a specific treatment intervention procedure 
(see ClinicalTrials.gov Identifier NCT02520271, Ostrobothnia Depression Study [ODS], 2016 and [35]). The 
cut-off point for AUDIT was chosen because in Finnish clinical practice it indicates a significantly increased 
risk of harm due to alcohol [36,37]. In the present study setting the aim was to identify individuals with 
marked alcohol use problems with high specificity to obtain motivational interview as an add-on 
psychosocial treatment. 
After dropout at 6 weeks, 173 patients completed both the TCI-R and MADRS and were therefore eligible 
for inclusion in the main analysis of this study. Of these patients 61 (35%) showed marked alcohol use 
problems (AUP, h/dƐĐŽƌĞƐшϭϭͿƌŽƵŐŚůǇĐŽƌƌĞƐƉŽŶĚŝŶŐƚŽƚŚĞĐŽŵŽƌďŝĚŝƚǇƌĂƚŝŽŽĨϮ͗ϭ;ŽĨƐƵďƐƚĂŶĐĞƵƐĞ
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disorders in depressed patients) observed in clinical samples where nearly one third of patients with major 
depressive disorder also have substance use disorders [38]. Of the 61 AUP patients MINI diagnosis had 
been assessed in 60 cases at baseline, 44 (73%) of which had been diagnosed with lifetime AUD and of the 
other 112 patients (with AUDIT scores < 11) MINI diagnosis had been assessed in 107 cases, only 3 (3%) of 
which had been diagnosed with lifetime AUD. Seven (16%) patients that had been diagnosed with AUD had 
also other SUD, and two (2%) patients without AUD were diagnosed with some other SUD. There was no 
exclusion of patients according to substance use. Alcohol use problems were more common in male 
patients: (males 69% vs. females 31%, ʖ2=31.5, p < 0.001; odds ratio (OR) = 6.6, 95% confidence intervals 
(CI) = 3.3–13.2). The follow-up included assessment of patients’ MADRS scores again at 6-month and 24-
month time-points. 
2.3 Statistical methods 
Differences in continuous variables (AUDIT and MADRS scores, and TCI-R dimension scores) between 
dropouts and other patients were calculated with independent samples t-tests. Differences in nominal 
variables between dropouts and other patients and in the prevalence of AUP between genders were 
calculated with ʖ2 statistics. 
This study was conducted according to the intention-to-treat protocol and in cases of dropout MADRS 
scores were imputed in the follow-up according to the last observation carried forward (LOCF) method. This 
replaced missing values in MADRS follow-up with their last observed values at earlier follow-up time points. 
This replaced missing MADRS values in 32 (17%) cases at 6-month follow-up and in 93 (49%) cases at 24-
month follow-up. Exploratory analysis between LOCF MADRS scores and temperament or character scores 
was performed with Pearson’s correlation coefficients. 
A linear mixed effects model was used for the repeated measurement testing in the main analysis of the 
study. This model predicted LOCF MADRS scores from 6 weeks to 6 months and to 24 months with the 
scores of the seven temperament and character dimensions (NS, HA, RD, P, SD, C, and ST; at six weeks) 
used as explaining variables and was adjusted with AUP, gender, and AUP x gender and AUP x time 
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interactions. Individual-specific intercept and slope terms were used in the model. The -2 log likelihood 
information criteria was used in evaluating model fit and model with unstructured covariance structure was 
reported. Kenward-Roger adjustment of degrees of freedom was applied for estimates of fixed effects. The 
main analysis was performed with PROC MIXED, SAS version 9.4 (SAS Institute Inc., Cary, NC, USA) and all 
other analyses were performed with SPSS for Mac (version 24.0, IBM Inc., Armonk, New York, USA). 
3. Results 
The dropout rate in the study was 65 (27%) at six weeks, 91 (38%) at six months, and 147 (61%) at 24 
months, but no gender differences were seen at any assessment point. Of these patients, the clinical 
treatment had been concluded in co-operation with the patients in 10 (11%) cases during the first 6 months 
and in 28 (19%) cases before 24 months. The dropout analysis of the raw data revealed similar baseline 
MADRS scores in dropouts and other patients. Baseline AUDIT scores were higher in dropouts at both 
rating points (6 months: dropout 14.0±11.2 vs. other patients 8.9±8.6, p < 0.001; 24 months: 12.0±10.5 vs. 
8.7±8.5, p = 0.006 for t-test). Dropouts also had lower Self-Directedness at baseline than did other patients 
in dropout analysis at 6 months: dropout 117.9±18.3 vs. other patients 124.2±18.2, p = 0.02 for t-test, and 
had trending but non-significant difference at 24 months (p = 0.09). In the LOCF data there were no 
statistically significant differences between dropouts and other patients’ 6-month LOCF MADRS scores in 
the 6-month dropout analysis (p = 0.2 for t-test). Dropouts had higher 24-month LOCF MADRS scores in the 
24-month dropout analysis (dropout 12.9±8.9 vs. other patients 8.3±7.6, p < 0.001 for t-test). 
The main results emerging as predictors of depression treatment outcome (measured as MADRS scores) 
are presented in Table 2. Poorer outcome of depression was predicted by AUP x Time interaction together 
with low RD. The model resulted in steeper negative sloping of MADRS scores for non-AUP group when 
compared to AUP group x Time. This means that alcohol use problems associated with poorer outcome of 
depression in the follow-up from 6 weeks to 6 months and to 24 months. Low RD was the only 
temperament or character trait that was associated with depression outcome as a predictor of poorer 
outcome in the follow-up from 6 weeks to 6 and 24 months. 
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[Table 2] 
The distributions (mean±SD) for LOCF MADRS scores were: 1) 13.6±8.5 at 6 months and 2) 10.6±8.5 at 24 
months. The mean±SD for temperament and character dimensions at six weeks were: NS 99.7±16.7; HA 
113.4±18.9; RD 100.1±17.6; P 99.7±21.5; SD 125.4±17.3; C 131.9±18.0; ST 64.9±15.5. The Cronbach’s ɲ 
values for TCI-R dimensions have been reported elsewhere [16]. The MADRS scores, number of responders, 
remitted patients, and non-responders in follow-up are presented in Table 3. 
[Table 3] 
Pearson’s correlation coefficients between RD, HA and SD and LOCF MADRS scores were statistically 
significant for RD and MADRS scores at 6 months (r = -0.32, p < 0.001), HA and MADRS scores at 6 months (r 
= 0.18, p = 0.02), SD and MADRS scores at 6 months (r = -0.27, p < 0.001), HA and MADRS scores at 24 
months (r = 0.26, p = 0.001), and SD and MADRS scores at 24 months (r = -0.32, p < 0.001).  
4. Discussion 
The main hypotheses in this study were that temperament and character traits together with harmful 
alcohol use (assessed in the early stages of treatment) explain outcome of depression over a period of two 
years. The main finding in this study was that poorer outcome of depression was predicted by low Reward 
Dependence. Alcohol use problems were also associated with poorer outcome of depression in the follow-
up from 6 weeks to 6 months and to 24 months.  
4.1 Outcome of depression (from 6 weeks to 24 months) 
Poorer outcome of depression was predicted by low Reward Dependence in the linear mixed effects model 
adjusted with AUP, gender, AUP x gender and AUP x time. In contrast to some earlier studies our present 
and earlier findings suggest that Reward Dependence is associated with depression treatment outcome 
[4,16,26]. This difference in results could be explained by differences in patient samples, as patients with 
SUDs have been excluded in those earlier studies but not in this present one [4,16,26]. Our earlier and 
present results suggest that low RD predicts poorer outcome of depression particularly in depressed 
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patients with comorbid alcohol use problems. In line with these findings, one study in which patients with 
prior SUD were not excluded resulted in MDD patients in remission having higher RD than currently 
depressed patients [24]. More specifically, the presence of SUD together with severe mental illness (SMI, 
including patients with MDD or schizophrenia) seems to be associated with low RD as dually diagnosed 
patients have lower RD than do SUD patients, but there is no significant difference in trait RD between 
patients with SMI or SUD without the comorbidity of the other [3]. The finding of an association between 
high RD (at 6 weeks) and better outcome of depression together with our earlier finding may be explained 
by depression state-dependent alterations in brain reward pathway functions in patients comorbid with 
SUD, and hence confirm a possible association between Reward Dependence and depression treatment 
outcome when alcohol use problems are taken into account [16,39].  
Although high HA and low SD have been associated earlier with risk of recurrences of depressive episodes 
as well as impaired depression treatment response [4,5,25], surprisingly, in this study these temperament 
and character traits were not statistically significant in predicting the outcome of depression. One possible 
explanation for this would be that alcohol use problems in part mediate the association between these 
personality traits and depression outcome. This argument is justified because earlier findings have shown 
that AUDs are associated with both: 1) the development of more chronic courses of depressive 
symptomatology [1,2], and 2) high HA and low SD. More specifically high HA and low SD are both 
associated with dual diagnosis [3], and high HA also with more severe AUDs [22]. Moreover, it is plausible 
that lower ability to organized problem solving or greater distress associated with avoidant behavior that 
are associated with low SD and high HA, respectively, could predispose these individuals to a higher risk of 
alcohol use problems. Finding the Harm Avoidance and Self-Directedness statistically non-significant in 
predicting outcome of depression in our analysis with the control of AUP is in line with the argument that 
the association between high HA and low SD and poorer outcome of depression could be in part mediated 
by alcohol use problems.  
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In the main analysis AUP x Time was highly significant predictor of depression outcome and was associated 
with slower decline of MADRS scores in the follow-up when compared to non-AUP. This finding 
demonstrates the disruptive effect of alcohol use problems on the outcome of depression and is in line 
with earlier findings of the detrimental effect of AUDs on the course depression [1,2]. Novelty Seeking, 
Persistence, Self-Transcendence and Cooperativeness remained non-significant in predicting the outcome 
of depression when AUPs were taken into account. Although high NS could cause impaired response to 
antidepressive treatment because it is associated with more severe SUD symptomatology [6,18,20], it 
seems that high NS is not an important trait in the association with poorer outcome of depression when 
AUP are controlled. Similarly low Persistence seems to be a marker for more severe or chronic SUD 
[21,23,40], but it was not a significant marker in predicting depression outcome in this study. The results 
from different patient samples have been partially contradictory regarding associations between trait ST 
and depressive symptomatology and the present results suggest that ST alone is not significant in 
predicting depression outcome nor together with AUP [4,15,26,27]. Although high Cooperativeness could 
be protective of depression and associated with better drinking outcomes in depressed alcohol-dependent 
patients [4,6] it was a non-significant predictor of the outcome of depression together with alcohol use 
problems in this study and this association should be verified in larger samples. As gender has not been 
associated with severity or recurrence of MDD episodes [2], it was expected that it would likewise not 
predict depression outcome in this sample of more diverse depressed patients.  
4.2 Strengths and limitations 
In the mixed effects multivariate model we analyzed the factors predicting the outcome of depression 
(MADRS scores) across three different time-points (at 6 weeks, 6 months and 24 months). Because 
depressive episodes are on average of 6 months’ duration, the follow-up period up to 6 months is a good 
marker for responsiveness to anti-depressive treatment, whereas follow-up period up to 24 months is likely 
to reflect considerably more the long-term fluctuation in symptoms, also including relapses and 
recurrences of depressive episodes [41,42]. It was important to study the outcome across both of these 
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outcomes, because in the majority of cases recovery from depression is not a straightforward process but 
instead takes a fluctuating course with remissions, relapses, and recurrences of episodes [42]. Moreover, it 
is possible that traits associated with responsiveness to treatment could in part differ from the traits 
predisposing to recurrence of episodes and this could be interesting hypothesis to test in future studies in 
naturalistic samples [4].  
As there was marked dropout in this study, especially at 24-month follow-up, data imputation was 
conducted for the main analysis. The method of last observation carried forward was used even though it 
could result in more conservative results. It is possible that the LOCF method used in this study did not 
detect all relapses, but the risk that it would have markedly affected the results in this study was 
considered low because the naturalistic study setting allowed patients to continue in the study even if they 
had failed to attend at some earlier point. 
According to the theory of pathoplasticity, personality has a causal effect on the clinical course and 
outcome of depression; e.g., individual personality determines how patients recover from depression [7]. 
However, the association between depression and temperament is more complex, and the depressive state 
also leads to higher HA [5]. In addition, in this patient sample RD also showed potential state-dependent 
alterations [16], and increase in SD seems to be associated with recovery from depression [26]. Because 
depressive symptoms have been shown to alter temperament and character profiles, the six-week TCI-R 
assessments were considered as better representing the patients’ long-term temperament and character 
profiles and were used in the GLM analyses as explanatory variables. 
Due to the naturalistic setting we had more lenient inclusion criteria in this study than in other studies with 
depressed patients, and because of that our patient sample likely included more patients with different 
subtypes of depressive symptomatology [16]. The patients in this study also had marked comorbidities 
including life-time diagnosis of (hypo)mania in some cases, and a large proportion had AUD. Moreover, the 
seasonal patterns of depressive symptomatology or personality disorders were not controlled for in the 
main analysis. Therefore, these results are not directly applicable to “pure” MDD patients but are more 
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easily generalizable to the mixed populations seen in psychiatric secondary services. A few patients had 
other SUDs (in addition to AUDs) that were not specified but could have had an effect on the personality 
profile of these patients. However, because of the low number of patients with other SUDs this have not 
likely affected the results markedly. According to the treatment procedure only a portion of the patients 
underwent motivational interviewing in addition to behavioral activation therapy, and, although 
temperament is considered to reflect relatively stable traits, it is possible that this difference in treatment 
affected the results. Dropout in follow-up was linked with high AUDIT and low SD at baseline, which may 
also have affected the results.  
4.3 Conclusions 
Possibly due to the modifying effect of alcohol use problems, high Reward Dependence was associated with 
better anti-depressive treatment outcome at 6 months. Harm Avoidance and Self-Directedness did not 
predict depression outcome when alcohol use problems were controlled. 
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Table 1a. Sociodemographic data on the patient sample 
 
 
 
Table 1b. Baseline scores on BDI and AUDIT by gender 
 Men Women Total 
Baseline BDI mean 
(±SD) 
28.5 (6.80) 27.5 (7.59) 27.9 (7.30) 
Baseline AUDIT mean 
(±SD) 
15.1 (10.59) 7.9 (8.30) 10.7 (9.88) 
 
Abbreviations: BDI = Beck Depression Inventory; AUDIT = Alcohol Use Disorder Identification Test 
 Men Women Total 
 N % N % N % 
Total 94 38.8 148 61.2 242 100 
Marital status       
Single 34 36.9 39 29.1 73 32.3 
Married or cohabiting 39 42.4 71 53.0 110 48.7 
Divorced 19 20.7 21 15.7 40 17.7 
Widowed 0 0 3 2.2 3 1.3 
Education       
Primary school 4 4.3 3 2.2 7 3.1 
Comprehensive school 27 29.3 28 20.7 55 24.2 
Tertiary education 10 10.9 25 18.5 35 15.4 
Vocational school 33 35.9 54 40.0 87 38.3 
Upper secondary education 10 10.9 7 5.2 17 7.5 
Polytechnic or university 8 8.7 18 13.3 26 11.5 
Work status before sick leave       
Employed 39 42.9 67 50.0 106 47.1 
Unemployed 41 45.1 30 22.4 71 31.6 
Housewife/husband 0 0 10 7.5 10 4.4 
Pensioner  5 5.5 11 8.2 16 7.1 
Student 6 6.6 16 11.9 22 9.8 
Self-reported history of 
depression episode 
62 67.4 90 65.7 152 66.4 
First degree family history of 
depression 
33 35.9 56 41.5 89 39.2 
First degree family history of 
bipolar disorder 
4 4.3 10 7.4 14 6.2 
Table 2. Predictors of depression outcome (LOCF MADRS scores across the follow-up from 6 weeks to 6 
months and to 24 months)a 
 
-2 x log-likelihood = 3530 for the SAS input code and output results 
a Results from the linear mixed effects model with temperament and character dimension scores, gender, 
AUP, and AUP x Gender and AUP x Time interactions as explanatory variables 
bB for the temperament and character variables effect on the dependent variable 
Abbreviations: LOCF = Last observation carried forward; NS = Novelty Seeking; HA = Harm Avoidance; RD = 
Reward Dependence; P = Persistence; SD = Self-Directedness; C = Cooperativeness; ST = Self-
Transcendence; MADRS = Montgomery-Åsberg Depression Rating Scale; AUP = alcohol use problems 
Significant results are presented in bold face. 
 
Fixed effects LOCF MADRS scores 
 Estimateb SE t p 
Intercept 20.07 10.04 2.00 0.049 
NS at 6 weeks 0.04 0.03 1.16 0.25 
HA at 6 weeks 0.06 0.04 1.70 0.09 
RD at 6 weeks -0.11 0.04 -3.03 0.003 
P at 6 weeks -0.03 0.03 -1.10 0.27 
SD at 6 weeks -0.06 0.04 -1.59 0.11 
C at 6 weeks 0.02 0.04 0.56 0.58 
ST at 6 weeks 0.05 0.03 1.49 0.14 
Male gender 0.24 1.76 0.14 0.23 
AUP 3.67 1.64 2.25 0.12 
AUP x Male gender -3.24 2.19 -1.48 0.14 
AUP x Time -0.10 0.05 -1.98 0.0002 
non-AUP x Time -0.33 0.06 -3.75 0.0002 
Table 3. MADRS scores in raw data, LOCF data, and by patient subgroup and number of responders, 
patients in remission and non-responders at baseline and follow-up 
  baseline 6 weeks  6 months  24 months  
Raw data MADRS scores (mean±SD) 23.2±6.7; n=228 
16.9±8.0; 
n=188 
13.1±8.7; 
n=156 
8.3±7.6; 
n=95 
Response* (n, %)    69, 44% 64, 67% 
Remission** (n, %)    49, 31% 50, 53% 
LOCF data MADRS scores, n=188   13.6±8.5 10.6±8.5 
Response* (n, %)    80, 43% 112, 60% 
Remission** (n, %)    52, 28% 80, 43% 
MADRS scores of patient subgroups (Raw data scores): 
non-AUP (mean±SD) 22.9±6.7 (n=136) 
16.7±8.0 
(n=123) 
12.8±8.7 
(n=105) 
6.7±6.2 
(n=66) 
AUP (mean±SD) 23.7±6.7 (n=92) 
17.2±8.1 
(n=65) 
13.7±8.7 
(n=51) 
12.0±9.2 
(n=29) 
Female (mean±SD) 22.3±6.8 (n=137) 
15.7±7.8 
(n=112) 
11.6±8.2 
(n=97) 
7.1±6.6 
(n=64) 
Male (mean±SD) 24.6±6.3 (n=91) 
18.6±8.0 
(n=76) 
15.6±9.1 
(n=59) 
10.8±8.9 
(n=31) 
proportion of men (n, %) 91, 40% 76, 40% 59, 38% 31, 33% 
proportion of AUP patients (n, %) 92, 40% 65, 35% 51, 33% 29, 31% 
Number of patients with increase in 
symptoms from baseline (n, %)      23, 15%  3, 3% 
Abbreviations: AUP= Alcohol use problems; MADRS = Montgomery-Åsberg Depression Rating Scale; LOCF = 
last observation carried forward 
*at least 50% MADRS score decline from baseline; **MADRS scores < 8 
 
